Delivery Order SPE2DR25D2006-SPE2DR26F56LS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order valued at $15,817.44 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and...
- The Defense Logistics Agency awarded a delivery order valued at $34,433.39 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The product is an antimalarial medication commonly used for malaria...
- The Defense Logistics Agency awarded a delivery order valued at $10,096.69 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 100 tablets, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment in military...
- The Defense Logistics Agency awarded a delivery order valued at $38,258.58 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.76 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s, a antimalarial medication commonly used for malaria prophylaxis and treatment in military personnel and Department of Defense beneficiaries. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed price procurement with no set-aside designation, indicating competitive award to this qualified...
- The Defense Logistics Agency awarded a delivery order valued at $2,854.36 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $9,402.12 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count). This is a firm fixed-price, non-set-aside competitive award with a completion date of May 7, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $5,508.34 to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by the Department of Defense for malaria prophylaxis in military personnel. This competitively awarded, firm fixed-price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56LSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,905.94 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count) on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The pharmaceutical product is an antimalarial medication commonly used for malaria prevention and treatment in military and federal healthcare populations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply for Department of Defense medical operations. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, leverages this comprehensive IDC vehicle to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems, the Defense Health Agency, and other government customers worldwide. The company's federal contract portfolio demonstrates consistent capability to deliver both high-volume and specialized pharmaceutical products through competitive, firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 12/2/25 |